Browse by Journal Title

Article

Benefits and risks of aliskiren treatment in patients with type 2 diabetes: analyses of the 3A registry.
Kistner, I., Zeymer, U., Dechend, R., Hagedorn, I., Riemer, T., Bramlage, P., Pittrow, D., Senges, J. and Schmieder, R.E.
Journal of Clinical Hypertension 18 (10): 1045-1053. October 2016

Two-year outcomes of patients treated with aliskiren under clinical practice conditions: non-interventional prospective study.
Zeymer, U., Dechend, R., Riemer, T., Deeg, E., Senges, J., Pittrow, D. and Schmieder, R.
Journal of Clinical Hypertension 18 (7): 647-654. July 2016

Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.
Dechend, R., Kaiser, E., Derer, W., Deeg, E., Busjahn, A., Schmieder, R.E. and Zeymer, U.
Journal of Clinical Hypertension 14 (8): 496-501. August 2012

Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension.
Jordan, J. and Biaggioni, I.
Journal of Clinical Hypertension 4 (2): 139-145. March 2002